אינטגרילין 2 מגמל

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

유효 성분:

EPTIFIBATIDE

제공처:

MERCK SHARP & DOHME (ISRAEL - 1996) COMPANY LTD, ISRAEL

ATC 코드:

B01AC16

약제 형태:

תמיסה להזרקה

구성:

EPTIFIBATIDE 2 MG/ML

관리 경로:

תוך-ורידי

처방전 유형:

מרשם נדרש

Manufactured by:

SCHERING-PLOUGH LABO. N.V , BELGIUM

치료 그룹:

EPTIFIBATIDE

치료 영역:

EPTIFIBATIDE

치료 징후:

Integrilin is indicated for the prevention of death and myocardial infarction in patients presenting with high risk unstable angina or non-Q-wave myocardial infarction. Integrilin is indicated in patients who are managed with standard medical therapies and/or with percutaneous coronary intervention. Integrilin is also indicated as an adjunct to percutaneous transluminal coronary angioplasty (PTCA) balloon angioplasty, directional atheretomy, transluminal extraction catheter atherectomy, rotational ablation angioplasty, or excimer laser angioplasty for the prevention of abrupt closure of the treated coronary vessel and related acute ischemic cardiac complications (death, myorardial infarction, need for urgent intervention). Integrilin is intended for use with aspirin and heparin.

승인 날짜:

2013-10-31